Risk of Lymphoma Following Exposure to Calcineurin Inhibitors and Topical Steroids in Patients with Atopic Dermatitis

This publication has 32 references indexed in Scilit:

• Safety and Tolerability of 1% Pimecrolimus Cream Among Infants: Experience With 1133 Patients Treated for Up to 2 Years
  Pediatrics, 2006
• Do steroids increase lymphoma risk? A case–control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis
  Annals of the Rheumatic Diseases, 2005
• Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern?
  British Journal of Dermatology, 2005
• A Multicenter Study of the Pharmacokinetics of Tacrolimus Ointment after First and Repeated Application to Children with Atopic Dermatitis
  Journal of Investigative Dermatology, 2005
• Post-Transplant Lymphoproliferative Disorder in Children
  Pediatric Drugs, 2005
• T‐cell post‐transplantation lymphoproliferative disorders after cardiac transplantation: a single institutional experience
  British Journal of Haematology, 2004
• Skin Cancers and Non-Hodgkin Lymphoma Among Users of Systemic Glucocorticoids: A Population-Based Cohort Study
  JNCI Journal of the National Cancer Institute, 2004
• Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France
  Blood, 2002
• Atopic eczema: its impact on the family and financial cost
  Archives of Disease in Childhood, 1997
• A prospective study of cancer incidence in a cohort examined for allergy
  Allergy, 1995